The Human Reduced Folate Carrier Gene Is Regulated by the AP2 and Sp1 Transcription Factor Families and a Functional 61-Base Pair Polymorphism
Recently, our laboratory reported an intricate regulation of the human reduced folate carrier (hRFC) gene, involving multiple promoters and noncoding exons. We localized promoter activity to a 452-bp GC-rich region upstream of noncoding exon A, including a 47-bp basal promoter with a CRE/AP-1-like c...
Gespeichert in:
Veröffentlicht in: | The Journal of biological chemistry 2002-11, Vol.277 (46), p.43873-43880 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Recently, our laboratory reported an intricate regulation of the human reduced folate carrier (hRFC) gene, involving multiple
promoters and noncoding exons. We localized promoter activity to a 452-bp GC-rich region upstream of noncoding exon A, including
a 47-bp basal promoter with a CRE/AP-1-like consensus element that bound the bZip family of DNA-binding proteins ( e.g. CREB-1 and c-Jun). We now report that three nearly identical tandem repeats (49â61 bp) in the hRFC-A upstream region are involved
in regulating promoter activity. By in vitro binding assays, multiple transcription factors ( e.g. AP2 and Sp1/Sp3) bound this region. When AP2 was cotransfected with the hRFC-A reporter construct into HT1080 cells, promoter
activity increased 3-fold. In Drosophila SL2 cells, Sp1 transactivated promoter A and showed synergism with CREB-1. However, c-Jun was antagonistic to the effects
of Sp1. A sequence variant in the hRFC-A repeated region was identified, involving an exact duplication of a 61-bp sequence.
This variant had an allelic frequency of 78% in 72 genomic DNAs and resulted in a 63% increase in promoter activity. These
results identify important regions in the hRFC-A promoter and critical roles for AP2 and Sp1, in combination with the bZip
transcription factors. Moreover, they document a functionally novel polymorphism that increases promoter activity and may
contribute to interpatient variations in hRFC expression and effects on tissue folate homeostasis and antitumor response to
antifolates. |
---|---|
ISSN: | 0021-9258 1083-351X |
DOI: | 10.1074/jbc.M208296200 |